Unknown

Dataset Information

0

The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection.

ABSTRACT: Genetic polymorphisms at the IFNL4 loci are known to influence the clinical outcome of several different infectious diseases. Best described is the association between the IFNL4 genotype and hepatitis C virus clearance. However, an influence of the IFNL4 genotype on the adaptive immune system was suggested by several studies but never investigated in humans. In this cross-sectional study, we have genotyped 201 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive participants for 3 IFNL4 polymorphisms (rs368234815, rs12979860, and rs117648444) and stratified them according to the IFNλ4 activity. Based on this stratification, we investigated the association between the IFNL4 genotype and the antibody as well as the CD8+ T cell response in the acute phase of the SARS-CoV-2 infection. We observed no differences in the genotype distribution compared with a Danish reference cohort or the 1,000 Genome Project, and we were not able to link the IFNL4 genotype to changes in either the antibody or CD8+ T cell responses of these patients.

SUBMITTER: Mohlenberg M 

PROVIDER: S-EPMC8820097 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection.

Møhlenberg Michelle M   Monrad Ida I   Vibholm Line K LK   Nielsen Stine S F SSF   Frattari Giacomo Schmidt GS   Schleimann Mariane Høgsbjerg MH   Olesen Rikke R   Kjolby Mads M   Gunst Jesper Damsgaard JD   Søgaard Ole Schmeltz OS   O'Brien Thomas R TR   Tolstrup Martin M   Hartmann Rune R  

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20211101 11

Genetic polymorphisms at the <i>IFNL4</i> loci are known to influence the clinical outcome of several different infectious diseases. Best described is the association between the <i>IFNL4</i> genotype and hepatitis C virus clearance. However, an influence of the <i>IFNL4</i> genotype on the adaptive immune system was suggested by several studies but never investigated in humans. In this cross-sectional study, we have genotyped 201 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-posi  ...[more]

Similar Datasets

Unknown Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives.
| S-EPMC9727711 | biostudies-literature
Unknown A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection
| S-SCDT-EMBOR-2021-54341-T | biostudies-other
Unknown Nirmatrelvir treatment of SARS-CoV-2 infected mice blunts antiviral adaptive immune responses
| S-SCDT-10_15252-EMMM_202317580 | biostudies-other
Unknown Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic study.
| S-EPMC8646571 | biostudies-literature
Unknown mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection.
| S-EPMC10783604 | biostudies-literature
Unknown Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.
| S-EPMC8084627 | biostudies-literature
Unknown Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection.
| S-EPMC8983140 | biostudies-literature
Unknown Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
| S-EPMC7426596 | biostudies-literature
Unknown SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
| S-EPMC8831226 | biostudies-literature
Unknown SARS-CoV-2 infection and the antiviral innate immune response.
| S-EPMC7798998 | biostudies-literature